Join to view full profile
808 S 52nd StRogers, AR 72758
Phone+1 479-936-9900
Fax+1 479-936-9944
Dr. Schaefer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2003 - 2006
The University of Toledo College of MedicineClass of 2003
Certifications & Licensure
AR State Medical License 2009 - 2028
NC State Medical License 2003 - 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2013-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2013-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2013-2017
Clinical Trials
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Publications & Presentations
PubMed
- 1 citationsRemote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic Malignancies.Benjamin A Derman, James H Essell, Mustafa S Ascha, Michael A Kolodziej, Lavi Kwiatkowsky
JCO Oncology Practice. 2026-04-10 - 2 citationsInhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel.Alfonso M Durán, Kristen Whitley, Krystal Santiago, Christian Yoo, Giancarlo Valdez
Cancers. 2025-04-30 - 8 citationsA phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer.Byoung Chul Cho, Melissa Johnson, Jair Bar, Eric Schaefer, Kiyotaka Yoh
Lung Cancer. 2025-04-01
Press Mentions
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC PatientsApril 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
